Pharming Group NV (PHAR)
17.60
+0.12
(+0.69%)
USD |
NASDAQ |
Dec 11, 16:00
17.60
0.00 (0.00%)
After-Hours: 18:48
Pharming Group Shareholders Equity (Quarterly): 264.64M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CorMedix, Inc. | 374.13M |
| uniQure NV | 228.75M |
| Kiniksa Pharmaceuticals International Plc | 535.38M |
| ProQR Therapeutics NV | 67.06M |
| Merus NV | 774.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 473.78M |
| Total Liabilities (Quarterly) | 209.14M |
| Debt to Equity Ratio | 0.4947 |
| Current Ratio | 3.158 |
| Net Debt Paydown Yield | 0.04% |